Table 5.
Relationship between group A and group B female subjects
| Hrs | Group A) (X±SD) | Group B (X±SD) | ‘t’ value | ‘P’ value | Significance of B |
|---|---|---|---|---|---|
| 0 | 7±1.88 | 8.2±1.74 | 4.80 | <0.001 | Highly Significant |
| 6 | 5.8±1.16 | 4.4±2.02 | 3.15 | <0.001 | Highly Significant |
| 12 | 5.0±1.47 | 6.1±1.80 | 2.9 | <0.01 | Moderate Significant |
| 18 | 2.7±1.18 | 3.3±1.99 | 1.66 | >0.05 | Not Significant |
| 24 | 3.4±1.91 | 4.0±2.06 | 1.36 | >0.05 | Not Significant |
| 30 | 4.6±1.17 | 3.38±1.06 | 3.20 | <0.01 | Moderate Significant |
| 36 | 4.2±1.20 | 4.35±1.27 | 0.55 | >0.05 | Not Significant |
| 42 | 2.6±1.73 | 3.0±1.60 | 1.35 | >0.05 | Not Significant |
| 48 | 1.6±1.33 | 1.30±0.56 | 1.36 | >0.05 | Not Significant |
X=mean of differnce between pre and post drug mean map at definite time intervals